This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Siegfried (Nantong) Pharmaceuticals Co. Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Christian Lothschuetz: Innovator in Pharmaceutical Processes
Introduction
Christian Lothschuetz is a notable inventor based in Rheinfelden, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the production of specialized chemical compounds. His innovative approach has led to the development of a unique process that enhances efficiency and sustainability in pharmaceutical manufacturing.
Latest Patents
Lothschuetz holds a patent for a process for the production of N-Boc-2-amino-3,3-dimethylbutyric acid. This invention involves a reaction of tert-Leucine with di-tert-butyl-dicarbonate. The process includes several steps: contacting tert-Leucine with di-tert-butyl-dicarbonate in an aqueous medium, optionally using a first organic solvent and an inorganic base, and isolating the product through precipitation at acidic pH. This method is designed to be environmentally friendly, minimizing waste while achieving good yields.
Career Highlights
Christian Lothschuetz is currently associated with Siegfried (Nantong) Pharmaceuticals Co. Ltd. His work at this company reflects his commitment to advancing pharmaceutical processes and improving product quality. His innovative techniques are paving the way for more sustainable practices in the industry.
Collaborations
Lothschuetz collaborates with talented professionals in his field, including Jiang Chen and Beat Theodor Weber. These partnerships enhance the research and development efforts within the pharmaceutical sector, fostering innovation and progress.
Conclusion
Christian Lothschuetz is a prominent figure in the pharmaceutical industry, recognized for his innovative processes and commitment to sustainability. His contributions are shaping the future of pharmaceutical manufacturing, making it more efficient and environmentally friendly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile